Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Apellis Pharmaceuticals (APLS)

Apellis Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:APLS
DateTimeSourceHeadlineSymbolCompany
05/06/202421:50Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APLSApellis Pharmaceuticals Inc
05/06/202412:00GlobeNewswire Inc.Apellis Pharmaceuticals to Host a Fireside Chat at the Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:APLSApellis Pharmaceuticals Inc
24/05/202415:00GlobeNewswire Inc.Positive One-Year Data from Phase 2 Study of Pegcetacoplan in Post-Transplant Recurrence of C3G and IC-MPGN Presented as Late-Breaker at ERA CongressNASDAQ:APLSApellis Pharmaceuticals Inc
21/05/202421:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APLSApellis Pharmaceuticals Inc
14/05/202413:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APLSApellis Pharmaceuticals Inc
14/05/202413:00GlobeNewswire Inc.Apellis Pharmaceuticals Refinances Existing Debt with Up to $475 Million Non-Dilutive Credit Facility from Sixth StreetNASDAQ:APLSApellis Pharmaceuticals Inc
09/05/202422:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APLSApellis Pharmaceuticals Inc
08/05/202422:13Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:APLSApellis Pharmaceuticals Inc
07/05/202412:05GlobeNewswire Inc.Apellis Pharmaceuticals Reports First Quarter 2024 Financial ResultsNASDAQ:APLSApellis Pharmaceuticals Inc
07/05/202412:02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:APLSApellis Pharmaceuticals Inc
06/05/202412:00GlobeNewswire Inc.Apellis Pharmaceuticals to Host a Fireside Chat at the Bank of America Securities Healthcare ConferenceNASDAQ:APLSApellis Pharmaceuticals Inc
01/05/202412:00GlobeNewswire Inc.Apellis Announces 11 Oral Presentations at the Association for Research in Vision and Ophthalmology (ARVO) Annual MeetingNASDAQ:APLSApellis Pharmaceuticals Inc
26/04/202412:15GlobeNewswire Inc.Apellis Announces Pegcetacoplan MAA Review Has Been Reset to Day 180 of Initial Assessment by European Medicines Agency (EMA)NASDAQ:APLSApellis Pharmaceuticals Inc
23/04/202412:00GlobeNewswire Inc.Apellis Pharmaceuticals to Host Conference Call on May 7, 2024, to Discuss First Quarter 2024 Financial ResultsNASDAQ:APLSApellis Pharmaceuticals Inc
04/04/202421:05GlobeNewswire Inc.Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:APLSApellis Pharmaceuticals Inc
01/04/202412:00GlobeNewswire Inc.Apellis Pharmaceuticals to Host a Fireside Chat at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:APLSApellis Pharmaceuticals Inc
11/03/202420:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APLSApellis Pharmaceuticals Inc
11/03/202411:00GlobeNewswire Inc.Apellis Appoints Leading Expert Dr. Philip Ferrone as Chief Medical Retina AdvisorNASDAQ:APLSApellis Pharmaceuticals Inc
08/03/202421:10Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:APLSApellis Pharmaceuticals Inc
08/03/202412:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APLSApellis Pharmaceuticals Inc
06/03/202421:05GlobeNewswire Inc.Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:APLSApellis Pharmaceuticals Inc
05/03/202421:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APLSApellis Pharmaceuticals Inc
05/03/202421:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APLSApellis Pharmaceuticals Inc
01/03/202421:25Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:APLSApellis Pharmaceuticals Inc
01/03/202418:37Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:APLSApellis Pharmaceuticals Inc
29/02/202422:10Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:APLSApellis Pharmaceuticals Inc
27/02/202412:35Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:APLSApellis Pharmaceuticals Inc
27/02/202412:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APLSApellis Pharmaceuticals Inc
27/02/202412:05GlobeNewswire Inc.Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:APLSApellis Pharmaceuticals Inc
27/02/202412:01Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:APLSApellis Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:APLS

Your Recent History

Delayed Upgrade Clock